Proton Collaborative Group
Clinical trials sponsored by Proton Collaborative Group, explained in plain language.
-
Proton therapy breakthrough: fewer radiation sessions could boost lung cancer survival
Disease control OngoingThis study tests a new way to deliver proton radiation for stage II-III non-small cell lung cancer. Instead of standard daily doses over many weeks, patients receive higher doses per session (hypofractionation) over a shorter time, combined with chemotherapy. The goal is to find …
Phase: PHASE1, PHASE2 • Sponsor: Proton Collaborative Group • Aim: Disease control
Last updated Jun 26, 2026 15:10 UTC
-
Proton therapy showdown: 5 sessions vs. 44 for prostate cancer
Disease control OngoingThis phase 3 trial is testing whether a shorter course of proton radiation (5 sessions over 1-2 weeks) works as well as the standard longer course (44 sessions over 8-9 weeks) for men with low-risk prostate cancer. The study involves 150 participants and will compare how well eac…
Phase: PHASE3 • Sponsor: Proton Collaborative Group • Aim: Disease control
Last updated Jun 26, 2026 14:00 UTC
-
New radiation technique aims to spare heart in breast cancer patients
Disease control OngoingThis study is testing a precise type of radiation called proton therapy for women with stage II or III breast cancer who need radiation to the whole breast or chest wall and lymph nodes. The goal is to see if this approach causes fewer side effects, especially to the heart, compa…
Phase: PHASE2 • Sponsor: Proton Collaborative Group • Aim: Disease control
Last updated Jun 26, 2026 13:57 UTC